Importance of β-Catenin and DRP-1 Expression in Hepatocellular Carcinomas

Yıl 2025, Cilt: 8 Sayı: 5, 197 - 201, 15.09.2025

Sevilay Özmen , Elif Demirci , Rabia Demirtaş , Onur Ceylan , Keziban Ülke Esin , Salih Kara , Nurhak Aksungur , Necip Altundaş , Fatih Alper , Hakan Dursun , Gürkan Öztürk , İbrahim Karabulut , Rabia Selen

https://doi.org/10.19127/bshealthscience.1666393

Öz

Hepatocellular carcinoma (HCC) represents one of the most prevalent primary liver malignancies. The activation of the Wnt/β-catenin signaling pathway is frequently observed in HCC, contributing to tumor progression. Dynamin-related protein-1 (DRP-1) is involved in apoptosis, tumor metastasis, and suppression of cell adhesion and migration. While DRP-1 and β-catenin have been reported in various tumors, their significance in HCC remains controversial. This study investigates the immunohistochemical (IHC) expression of β-catenin and DRP-1 in HCC. Thirty HCC cases diagnosed within the last 15 years at our institution were included. IHC staining with β-catenin and DRP-1 antibodies was performed on paraffin-embedded tumor and non-tumor tissue samples. Thus, the expressions of these proteins were analyzed. Among 30 cases, 25 had a cirrhotic background, while 5 were non-cirrhotic. IHC analysis revealed membranous β-catenin reactivity in tumor areas in 29 cases, with one case exhibiting both membranous and nuclear reactivity. Weaker immunoreactivity was observed in non-tumoral hepatocytes and biliary epithelium compared to tumor areas. DRP-1 expression was absent in non-tumoral hepatocytes, while cytoplasmic immunoreactivity was statistically strong in 16 cases (53%) (P=0.0008). No correlation was found between nuclear grade, lymphovascular invasion, serum AFP levels, necrosis, survival, and β-catenin or DRP-1 expression (P>0.05). Our findings suggest a potential role for DRP-1 in HCC pathogenesis. While no significant correlation with prognostic parameters was observed in our limited cohort, further multicenter studies with larger, heterogeneous patient groups are warranted.

Anahtar Kelimeler

Hepatocellular carcinoma , DRP-1 , β-catenin , Apoptosis

Etik Beyan

The study was approved by the Clinical Research Ethics Council of Ataturk University (approval date: June 18, 2023, protocol code: B.30.2.ATA.0.01.00/681).

Kaynakça

• Bosman FT, Carneiro F, Hruban RH, Theise ND. 2010. WHO classification of tumours of the digestive system (4th ed). IARC Press, Lyon, France, pp: 45-85.
• Di Tommaso L, Franchi G, Park YN. 2007. Diagnostic value of HSP70, Glypican 3, and Glutamine Synthetase in hepatocellular nodules in cirrhosis. Hepatology, 45(3): 725–734.
• Durnez A, Verslype C, Nevens F. 2006. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma: A possible progenitor cell origin. Histopathology, 49(2): 138–151.
• Eisner V, Picard M, Hajnóczky G. 2018. Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat Cell Biol, 20(6): 755–765.
• El-Serag HB, Rudolph KL. 2007. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology, 132(6):2557–2576.
• Forner A, Vilana R, Ayuso C. 2008. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology, 47(1): 97–104.
• Hu C, Huang Y, Li L. 2017. Drp1-dependent mitochondrial fission plays critical roles in physiological and pathological progress in mammals. Int J Mol Sci, 18(1): 144.
• Lima AR, Santos L, Correia M. 2018. Dynamin-related protein 1 at the crossroads of cancer. Genes, 9(2): 115.
• Ma M, Lin XH, Liu HH, Zhang R, Chen RX. 2020. Suppression of DRP1 mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy. Oncol Rep, 43(3): 1010–1018.
• Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M, Zucman-Rossi J. 2014. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology, 60(6): 1983–1992.
• Qian W, Wang J, Van Houten B. 2013. The role of dynamin-related protein 1 in cancer growth: A promising therapeutic target? Expert Opin Ther Targets, 17(9): 997–1001.
• Rehman J, Zhang HJ, Toth PT. 2012. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J, 26(6): 2175–2186.
• Roskams T, Kojiro M. 2010. Pathology of early hepatocellular carcinoma: Conventional and molecular diagnosis. Semin Liver Dis, 30(1): 17–25.
• Schulze K, Imbeaud S, Letouzé E, Alexandrov LB, Calderaro J, Rebouissou S. 2015. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet, 47(5): 505–511.
• Shen F, Gai J, Xing J. 2018. Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549. Biochem Biophys Res Commun, 495(1): 1158–1166.
• Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. 2019. A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 16(10): 589–604.
• Zhai J, Wang Y, Yang F, Hu J, Qi Q, Zhang Y. 2014. DRP-1, ezrin, and E-cadherin expression and their association with esophageal squamous cell carcinoma. Oncol Lett, 8(1): 133–138.
• Zhao J, Zhang J, Yu M. 2013. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene, 32(40): 4814–4824.
• Zhao T, Guo BJ, Xiao CL, Chen JJ, Lü C, Fang FF, Li B. 2021. Aerobic exercise suppresses hepatocellular carcinoma by downregulating dynamin-related protein 1 through the PI3K/AKT pathway. J Integr Med, 19(5): 418–427.